Reductions in HIV risk behaviors among depressed drug injectors

American Journal of Drug and Alcohol Abuse

Volumn 31, Issue 3, 2005, Pages 417-432

  Stein, Michael D ^a,b   Anderson, Bradley J ^a   Solomon, David A ^a   Herman, Debra S ^a   Ramsey, Susan E ^a   Brown, Richard A ^a   Miller, Ivan W ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Antidepressants; Drug psychotherapy combination; HIV risk; Mood disorders; Psychoactive substance use disorder; Unipolar

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; VENLAFAXINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DYSTHYMIA; FEMALE; FOLLOW UP; HAMILTON SCALE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK REDUCTION; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; RHODE ISLAND; RISK REDUCTION BEHAVIOR; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 23744473772     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-200056793     Document Type: Article

References (26)

1. Croughan JL, Miller JP, Wagelin D, Whitman BY. Psychiatric illness in male and female narcotic addicts. J Clin Psychiatry 1982; 43:225-228.
2. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry 1982; 39:151-156.
3. Brienza RS, Stein MD, Chen MH, Gogineni A, Sobota M, Maksad J, Hu P, Clarke J. Depression among needle exchange program and methadone maintenance clients. J Sub Abuse Treat 2000; 18:331-337.
4. Rounsaville BJ, Kosten TR, Weisman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: A 2.5 year follow-up study. Arch Gen Psychiatry 1986; 43:739-745.
5. Carroll KM, Power MED, Bryant K. One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as predictors of outcome. J Nerv Men Dis 1993; 181:71-79.
6. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatment: Role of psychiatric severity. Arch Gen Psychiatry 1983; 40:620-625.
7. Woody GE, Luborsky L, McLellan T, O'Brien CP, Beck AT, Blaine J, Herman I, Hole A. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 1983; 40:639-645.
8. Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and HIV injection risk behaviors. Am J Psychiatry 2003; 160:1659-1662.
9. Marlatt GA, Gordon JR. Relapse Prevention. New York: Guilford Press, 1985.
10. Kang S, De Leon G. Correlates of drug injection behaviors among methadone outpatients. Am J Drug Alc Abuse 1993; 19:107-118.
11. Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alc Abuse 1999; 25:117-127.
12. Stein MD, Solomon DA, Herman DS, Anthony JL, Ramsey SE, Anderson BJ, Miller IW. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatry 2004; 61:152-159.
13. Stein MD, Solomon DA, Anderson BJ, Herman DS, Anthony JL, Ramsey SE, Brown RA, Miller IW. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users. Am J Addict. In press.
14. Keller M, McCullough J, Klein D, Arnow B, Dunner D, Gelenberg A, Markowitz J, Nemeroff C, Russell J, Thase M, Trivedi M, Zajecka J, Blalock J, Borian F, Fawcett J, Hirschfeld R, Jody D, Keitner G, Kocsis J, Koran L, Kornstein S, Manber R, Miller I, Ninan P, Rothbaum B, Rush A, Schatzberg A. The acute treatment of chronic major depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. N Engl J Med 2000; 342: 1462-1470.
15. Miller IW, Keitner GI. Combined medication and psychotherapy in the treatment of chronic mood disorders. Psychiatr Clin North Am 1996; 19:151-171.
16. First M, Spitzer R, Williams J, Gibbons M. Structured Clinical Interview for DSM-IV-Patient Version. New York: Biometrics Research Department, New York State Psychiatric Institute, 1995.
17. Miller IW, Bishop S, Norman WH, Maddever H. The modified hamilton rating scale for depression: reliability and validity. Psychiatry Res 1985; 14:131-142.
18. Brown RA, Evans DM, Miller IW, Burgess ES, Mueller TI. Cognitive-behavioral treatment for depression in alcoholics. J Consult Clin Psychol 1997; 65:715-726.
19. Lewinsohn PM, Graf M. Pleasant activities and depression. J Consult Clin Psychol 1973; 41:261-268.
20. Fawcett J, Epstein P, Fiester S, Elkin I, Autry J. Clinical management-imipramine/placebo administration manual: NIMH treatment of depression collaborative research program. Psychopharmacol Bull 1987; 23:309-324.
21. Navaline HA, Snider EC, Petro CJ, Tobin D, Metzger D, Alterman AI, Woody GE. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retrovir 1994; 10:S281-S283.
22. Montgomery SA, Dufour H, Brion S. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988; 9:69-76.
23. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9:199-213.
24. Stein MD, Herman DS, Solomon DA, Anthony JL, Anderson BJ, Ramsey SE, Miller IW. Adherence to treatment of depression in active injection drug users: the MINERVA study. J Subst Abuse Treat 2004; 26:87-93.
25. Nelson JC. Overcoming treatment resistance in depression. J Clin Psychiatry 1998; 59:13-19.
26. Primm AB, Gomez MB, Tzolova-Iontchev I, Perry W, Vu HT, Crum RM. Mental health versus substance abuse treatment programs for dually diagnosed patients. J Subst Abuse Treat 2000; 19:285-290.